From the Journals

Increase in pediatric thyroid cancers: overdiagnosis or something more?


 

FROM CANCER

Overdiagnosis vs. environmental factors and lifestyle changes

If further investigations point to detection of subclinical disease as the cause of the increases in pediatric DTC incidence then initiatives may be needed to curtail use of CT scans, ultrasound, and needle biopsies, as has been done in adults, Dr. Chen and Dr. Davies said in their editorial.

“When the American Thyroid Association modified their guidelines for needle biopsy of nodules to discourage sampling of small lesions, a corresponding decrease in incidence rates was observed, suggesting that, indeed, overdiagnosis was the culprit,” they said.

Although it’s not clear what environmental factors or lifestyle changes are driving an increase, obesity has been consistently linked to increases in thyroid cancer, Dr. Goldenberg said. Conversely, smoking has been linked to reduced thyroid cancer risk, which means reduced prevalence of smoking in the community could potentially contribute to increased thyroid cancer incidence.

“It is our role as physicians to protect our patients from complacency and undertreatment,” he concluded in his editorial. “Explaining away thyroid cancers as being subclinical or clinically insignificant is reminiscent of days past when we told our patients: ‘Don’t worry, it’s good cancer.’ ”

The research by Dr. Shiels and colleagues was supported by the Intramural Research Program of the National Cancer Institute. Dr. Shiels and coauthors made no conflict of interest disclosures related to their report.

SOURCE: Shiels MO et al. Cancer. 2019 Apr 23. doi: 10.1002/cncr.32125.

Pages

Recommended Reading

Clinical trial: The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma
MDedge Hematology and Oncology
Enoblituzumab plus pembrolizumab shows promise for select solid tumors
MDedge Hematology and Oncology
Characteristics of mucinous adenocarcinoma highlighted
MDedge Hematology and Oncology
Antibiotics gut checkpoint inhibitor efficacy
MDedge Hematology and Oncology
ATA risk stratification for DTC performs well in real-world cohort
MDedge Hematology and Oncology
Mouthwash shows some efficacy for oral mucositis pain
MDedge Hematology and Oncology
Survival after squamous recurrence may be unaffected by immune status
MDedge Hematology and Oncology
BWH classification system better predicts outcomes in HNCSCC
MDedge Hematology and Oncology
Head and neck cancer cost analysis yields simple bundled payment model
MDedge Hematology and Oncology
High pCR rate in HPV+ HNSCC with nivolumab/SBRT
MDedge Hematology and Oncology